Fusion Pharmaceuticals (NASDAQ:FUSN) Reaches New 1-Year High

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $21.32 and last traded at $21.29, with a volume of 225039 shares trading hands. The stock had previously closed at $21.24. Analyst Ratings Changes Several analysts have commented on […]

Related Keywords

Canada , United States , Leerink Partnrs , Raymond James , Fusion Pharmaceuticals Stock Performance , Nasdaq , Royal Bank , Fusion Pharmaceuticals , Perceptive Advisors , Fusion Pharmaceuticals Inc , Hermes Inc , Institutional Trading Of Fusion Pharmaceuticals , News Ratings For Fusion Pharmaceuticals Daily , Sphera Funds Management , Fusion Pharmaceuticals Company Profile , Get Free Report , Capital Management , Partners Management , Funds Management , Pharmaceuticals Inc , Fusion Pharmaceuticals Daily , Nasdaq Fusn , Fusn , Medical , Stocks , Technicals ,